Decreased relapse risk after allogeneic hematopoietic stem cell transplantation (HSCT) in myelofibrosis with splenomegaly

被引：0
|
作者：
Ditschkowski, M. [1 ]
Steckel, N. K. [1 ]
Trenschel, R. [1 ]
Gromke, T. [1 ]
Beelen, D. W. [1 ]
机构：
[1] Univ Klinikum Essen, Klin Knochenmarktransplantat, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V707
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [21] Clonal Evolution after Allogeneic Hematopoietic Stem Cell Transplantation: The Case of Myelofibrosis
    Christopeit, Maximilian
    Badbaran, Anita
    Alawi, Malik
    Flach, Johanna
    Fehse, Boris
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) : E167 - E170
  • [22] Ruxolitinib for symptomatic patients with relapse of myelofibrosis after allogeneic hematopoietic transplantation
    Janson, D.
    Stuebig, T.
    Alchalby, H.
    Ayuk, F.
    Wolschke, C.
    Christopeit, M.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S210 - S210
  • [23] MYELOFIBROSIS GRADE II-III IS AN INDEPENDENT RISK FACTOR FOR RELAPSE OF ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Zhang, Haixiao
    Jiang, Erlie
    BONE MARROW TRANSPLANTATION, 2024, 59 : 174 - 174
  • [24] The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis
    Wolfe, Heather R.
    Horwitz, Mitchell E.
    Rein, Lindsay A. M.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (04):
  • [25] Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis
    Hussein, Ayad Ahmed
    Hamadah, Tuka
    Domm, Jennifer
    Al-Zaben, Abdulhadi
    Frangoul, Haydar
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 815 - 819
  • [26] Ocular surface and tear function after allogeneic hematopoietic stem cell transplantation(HSCT)
    Na, Kyung-Sun
    Joo, Choun-Ki
    Yoo, Young-Sik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Noninfectious infiltrative lung diseases after allogeneic hematopoietic stem cell transplantation (HSCT)
    Schlemmer, Frederic
    Chevret, Sylvie
    Lorillon, Gwenael
    De Bazelaire, Cedric
    De Latour, Regis Peffault
    Meignin, Veronique
    Michallet, Mauricette
    Hermet, Eric
    Wyplosz, Benjamin
    Houdouin, Veronique
    Marchand-Adam, Sylvain
    Socie, Gerard
    Tazi, Abdellatif
    Bergeron, Anne
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [28] Infections as the cause of late mortality after allogeneic hematopoietic stem cell transplantation (HSCT)
    Ljungman, P
    Remberger, M
    Sparrelid, E
    Aschan, J
    Barkholt, L
    Broliden, PA
    Gustafsson, B
    Löfgren, C
    Svennilson, J
    Winiarski, J
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2002, 29 : S36 - S36
  • [29] Complications after T-CELL depleted allogeneic hematopoietic stem cell transplantation (HSCT).
    Bieri, S
    Roosnek, E
    Helg, C
    Ozsahin, H
    Wacker, P
    Chapuis, B
    Miralbell, R
    Chalandon, Y
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 141 - 141
  • [30] Outcome of relapse after reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT) - The effect of the underlying disease on survival following relapse
    Singhal, Seema
    Frankfurt, Olga
    Evens, Andrew
    Gordon, Leo
    Tallman, Martin
    Williams, Stephanie
    Winter, Jane
    Grinblatt, David
    Kaminer, Lynne
    Mehta, Jayesh
    BLOOD, 2007, 110 (11) : 334B - 334B
12345